Viewing nowCombinationCredable Tablet 10/10 mg (Ezetimibe, Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmilm Pharmaceutical Co., Ltd.

MFDS item code 201601208 · Approved 2016.02.29 · Insurance code 645305450
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication is used as an adjunct to dietary therapy to lower elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol, while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It is primarily prescribed in conjunction with dietary therapy that restricts the intake of saturated fats and cholesterol, and is added when dietary therapy alone is insufficient. Additionally, it is used as a lipid-modulating agent for patients at high risk of atherosclerotic vascular diseases due to hypercholesterolemia. Prior to treatment, other causes of dyslipidemia, such as diabetes and hypothyroidism, should be identified, and if necessary, those causes should be treated first. Regular monitoring of cholesterol levels during treatment is also important for proper management. In summary, this drug is used to improve blood lipid levels caused by hypercholesterolemia and dyslipidemia to reduce the risk of cardiovascular diseases.
This medicine is taken once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients who are taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication may cause serious muscle problems, so any symptoms such as muscle pain or muscle weakness should be reported to a doctor immediately. Particularly, patients at high risk for serious myopathy or rhabdomyolysis should temporarily suspend or discontinue the use of this medication. It should not be used in individuals with a known allergy to the active ingredients or excipients, severe hepatic impairment, muscle diseases, severe renal failure, pregnant or potentially pregnant women, or breastfeeding mothers. Additionally, this medication contains lactose and should not be administered to patients with lactose intolerance. Caution is also advised for alcoholics or patients with a history of liver disease, severe myasthenia gravis, the elderly, and patients with diminished renal function; they should use this medication cautiously and undergo regular tests under a doctor’s supervision. This medication may affect liver function; therefore, liver function tests should be performed before administration and regularly during treatment. It may slightly increase blood glucose levels, so patients at risk for diabetes should monitor their blood glucose periodically. There may be potential interactions when taken with other drugs, so patients should inform their doctor or pharmacist of any medications they are taking. This medication is not recommended for women who are pregnant or breastfeeding, and fertile women should use appropriate contraception while taking it. Safety in children or adolescents has not been sufficiently established, so it is advisable not to use it without a doctor’s judgment. In case of overdose, as there is no specific antidote, appropriate treatment and supportive care should be provided according to symptoms, and liver function and muscle enzyme levels should be monitored. This medication should be kept out of the reach of children and should not be transferred to other containers.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated blood bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, strange sensation, drug intolerance, colon polyp, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscular weakness, cold sweats, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, angioedema, thrombocytopenia, nausea, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, arthralgia, myalgia, increased creatine phosphokinase, elevated liver aminotransferase levels, hepatitis, abdominal pain, paresthesia, depression, tremor, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastric area, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, hyperhidrosis, conjunctival injection, renal failure, abnormal liver function, increased blood creatinine, elevated blood pressure, increased blood urea, elevated CPK, abnormal liver function tests, myalgia, joint pain, increased CK, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture and is best kept at a temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication and prevent degradation.
White to almost white round film-coated tablets
30 tablets (10 tablets/PTP packaging x 3), 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmilm Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.